NCT06894511 2026-02-17
PSMAndARPI
Novartis
Phase 2 Active not recruiting
Clinical Trials
4 trialsNCT03874884 2025-05-14
LuPARP
Peter MacCallum Cancer Centre, Australia
Phase 1 Active not recruiting
NCT03724747 2024-11-08
Study to Evaluate the Safety, Tolerability,Pharmacokinetics, and Antitumor Activity of a Thorium-227 Labeled Antibody-chelator Conjugate Alone and in Combination With Darolutamide, in Patients With Metastatic Castration Resistant Prostate Cancer
Bayer
Phase 1 Completed
NCT05425862 2023-12-11
REPAIR
Peter MacCallum Cancer Centre, Australia
Phase 1 Suspended